Company Filing History:
Years Active: 2017
Title: Henry Korman: Innovator in GPR52 Modulation
Introduction
Henry Korman is a notable inventor based in Santee, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target GPR52. His work is crucial for addressing various neuropsychiatric disorders.
Latest Patents
Korman holds a patent for "1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto." This invention relates to compounds that modulate the activity of GPR52, which is implicated in several disorders, including Huntington's disease, schizophrenia, and ADHD. The patent outlines methods for treating a range of conditions, including mood disorders, anxiety disorders, and neurocognitive dysfunction.
Career Highlights
Henry Korman is currently associated with Arena Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing therapeutic solutions that can significantly improve the quality of life for individuals suffering from complex disorders.
Collaborations
Korman has collaborated with notable colleagues, including Yifeng Xiong and Andrew J Grottick. These partnerships have enhanced the research and development efforts at Arena Pharmaceuticals, leading to advancements in treatment options.
Conclusion
Henry Korman's contributions to the field of pharmaceutical innovation, particularly in GPR52 modulation, highlight his role as a key inventor. His work has the potential to impact the treatment of various neuropsychiatric disorders significantly.